Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity
-
Published:2024-02
Issue:
Volume:99
Page:117587
-
ISSN:0968-0896
-
Container-title:Bioorganic & Medicinal Chemistry
-
language:en
-
Short-container-title:Bioorganic & Medicinal Chemistry
Author:
Yang Hyun-MoORCID,
Lee Changsik,
Min Jaeki,
Ha Nina,
Bae Daekwon,
Nam GibeomORCID,
Park Hyun-JuORCID
Reference54 articles.
1. Histone deacetylases (HDACs): characterization of the classical HDAC family;de Ruijter;Biochem J,2003
2. Roles of histone acetyltransferases and deacetylases in gene regulation;Kuo;Bioessays,1998
3. Park J, Terranova-Barberio M, Zhong AY, Thomas S, Munster PN. Clinical applications of histone deacetylase inhibitors. In: Tollefsbol TO, editor. Handbook of epigenetics: the new molecular and medical genetics, 2nd ed. Handbook of Epigenetics. Elsevier; 2017:605-621.
4. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics;Gallinari;Cell Res,2007
5. HDAC inhibitors: a 2013–2017 patent survey;Faria Freitas;Expert Opin Ther Pat,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献